Author： Morris P.E. Hite R.D. Ohl C.
Publisher： Adis International
ISSN： 1173-8804
Source： BioDrugs, Vol.16, Iss.6, 2002-01, pp. : 403-417
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
In patients with severe sepsis, thrombin has been implicated in the interrelationship between the coagulation and inflammation pathways. Thrombin is responsible for conversion of fibrinogen to fibrin (thrombus formation). Thrombin also activates endothelial cells, white blood cells and platelets. Regulation of both the coagulation and inflammation pathways is in part through the interaction of thrombin and activated protein C. Activated protein C has particular attributes that may inhibit microvascular thrombi, promote fibrinolysis and directly dampen the pro-inflammatory aspect of infection. In patients with severe sepsis, many investigators have demonstrated an active coagulopathic state, with low protein C levels. A phase III clinical trial has now demonstrated reduced mortality in patients with severe sepsis receiving activated protein C.
Related content
Access to resources
Recommend
By Beattie Paul F Nelson Roger M Heintzelman Matthew
Physiotherapy Theory and Practice, Vol. 27, Iss. 4, 2011-05 ,pp. :